Curenetics
PrivateLast Round
Accelerator
Apr 14, 2026
Total Funding Raised
$140,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Curenetics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Accelerator round in April 2026.
Curenetics is a healthcare technology company that provides an AI-driven precision oncology platform designed to predict patient response to immunotherapy treatments.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Healthcare Analytics, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curenetics Comparables
Compare Curenetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VieCure | 77% | |
| BostonGene | 76% | |
| SOPHiA GENETICS | 69% |
For institutional investors. Book with your work email.
Curenetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 14, 2026 | ||||
| Grant | Oct 6, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Curenetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Quantum Computing Centre | Accelerator |
| Science and Technology Facilities Council | Accelerator |
| National Institute for Health and Care Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 12, 2026
Headcount grew 27% QoQ (from 15 to 19 employees)
- Apr 15, 2026
Grew 28% QoQ, from 18 to 23 employees.
For institutional investors. Book with your work email.
Curenetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Curenetics's valuation, stock price, and market status.
Is Curenetics a public or private company?
Curenetics is a private company.
What is the current stock price of Curenetics?
Curenetics is a private company, so its shares have no public market price. Caplight tracks Curenetics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curenetics worth (valuation)?
Valuation information for Curenetics is not publicly available.
Can I buy Curenetics stock?
Curenetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curenetics's last funding round?
Curenetics's most recent funding round was Accelerator on April 14, 2026.
Who are the main investors in Curenetics?
Key investors in Curenetics include National Quantum Computing Centre, Science and Technology Facilities Council, National Institute for Health and Care Research.
Will Curenetics IPO soon?
No public IPO plans have been announced for Curenetics.
How can I track Curenetics secondary market activity?
Caplight tracks bids, offers, and trades in Curenetics's shares on secondary markets.